425: Infleqtion to Go Public via Churchill Capital Corp X Merger
Merger Announcement
Infleqtion, a quantum technology leader, will merge with SPAC Churchill Capital Corp X, valuing the combined entity at $1.8 billion pre-money equity and securing over $540 million in gross proceeds.
Summary
- Infleqtion, a global leader in neutral atom-based quantum technology, is merging with Churchill Capital Corp X (NASDAQ: CCCX) to become a publicly traded company under the ticker INFQ.
- The business combination values Infleqtion at a pre-money equity value of $1.8 billion.
- The transaction is expected to provide over $540 million in gross proceeds, including $416 million from Churchill X's trust account (assuming no redemptions as of June 30, 2025) and over $125 million from a common stock PIPE investment.
- Key PIPE investors include Maverick Capital, Counterpoint Global (Morgan Stanley), Glynn Capital, BOKA Capital, and LCP Quantum.
- Infleqtion reported approximately $29 million in trailing twelve-month revenue as of June 30, 2025, reflecting an ~80% CAGR over the past two years.
- The company expects approximately $50 million in booked and awarded business by year-end 2025, representing potential multi-year value, and has identified a potential customer pipeline exceeding $300 million.
- Infleqtion's balance sheet shows $88 million in cash as of June 30, 2025, with a trailing twelve-month cash burn of $21 million.
- All existing Infleqtion shareholders will roll 100% of their equity into the combined company and will be subject to a 180-day lock-up period, with potential for early release if the volume-weighted average price (VWAP) of the common stock equals or exceeds $12.00 per share over 15 trading days within 180 consecutive trading days.
- The combined company's board of directors will consist of seven or nine directors, including one or two designated by the Sponsor.
- M. Klein & Company, through its affiliate The Klein Group, LLC, will provide financial advisory, strategic consulting, and business development services for a fixed cash retainer of $250,000 per quarter, with potential additional fees for capital markets financing or strategic investments.
Sentiment
Score: 8
Explanation: The filing presents a highly positive outlook on the merger, emphasizing Infleqtion's strong technical leadership, commercial traction, significant market opportunity, and robust financial position. The substantial capital raise and 100% equity rollover by existing shareholders further reinforce confidence. While risks inherent to emerging technologies are disclosed, the overall tone and presented metrics suggest strong growth potential and strategic positioning.
Positives
- Infleqtion is a commercial leader in quantum technology with real-world deployments in computing and precision sensing, trusted by industry leaders like NVIDIA, the U.S. Department of Defense, and NASA.
- Achieved industry-leading technical milestones including 1,600 physical qubits, 99.73% entangling fidelity, and demonstration of a real-world application using logical qubits.
- Strong commercial momentum with approximately $29 million in trailing twelve-month revenue as of June 30, 2025, reflecting an ~80% CAGR over the past two years.
- Significant future potential with approximately $50 million in booked and awarded business for year-end 2025 and a $300 million+ identified customer pipeline.
- The transaction provides over $540 million of expected gross proceeds, including over $125 million in incremental PIPE financing from leading institutional investors, strengthening Infleqtion's balance sheet.
- Infleqtion has a strong balance sheet with $88 million in cash as of June 30, 2025, and no debt.
- All existing Infleqtion shareholders are rolling 100% of their equity, aligning interests with new public shareholders.
- The company's neutral atom technology is recognized for scalability, flexibility, and cost efficiency, powering both quantum computing and precision sensing from a single product architecture.
Risks
- Infleqtion is pursuing an emerging technology, faces significant technical challenges, and may not achieve commercialization or market acceptance.
- The company has a history of net losses and a limited operating history.
- Future financial performance, capital requirements, and unit economics are subject to uncertainty.
- The competitive landscape in the quantum technology industry is evolving rapidly.
- Dependence on members of senior management and the ability to attract and retain qualified personnel is critical.
- Concentration of revenue in contracts with government or state-funded entities poses a risk.
- There is a potential need for additional future financing beyond the current capital raise.
- The company's ability to manage growth and expand operations effectively is a challenge.
- Reliance on strategic partners and other third parties for components and services is a risk.
- Maintaining, protecting, and defending intellectual property rights is crucial.
- Risks associated with privacy, data protection, or cybersecurity incidents and related regulations exist.
- Uncertainty or changes with respect to laws and regulations, taxes, trade conditions, and the macroeconomic environment could adversely affect the business.
- The combined company's ability to maintain internal control over financial reporting and operate as a public company is a new challenge.
- Required regulatory approvals for the proposed transaction may be delayed or not obtained, adversely affecting the combined company or expected benefits.
- Shareholders of Churchill X could elect to redeem their shares, leaving the combined company with insufficient cash to execute its business plans.
- The occurrence of any event, change, or other circumstance could give rise to the termination of the business combination agreement.
- The outcome of any legal proceedings or government investigations against Infleqtion or Churchill X is uncertain.
- Failure to realize the anticipated benefits of the proposed transaction is a risk.
- The ability of Churchill X or the combined company to issue equity or equity-linked securities in connection with the proposed transaction or in the future is uncertain.
Future Outlook
Infleqtion anticipates accelerating its technology and product roadmap, expanding applications into new end markets such as artificial intelligence, national security, and space, and scaling customer adoption and ecosystem partnerships. The company expects to leverage its neutral atom technology to unlock breakthroughs in AI, national security, materials science, and financial services, with quantum computing and sensing markets projected to exceed $160 billion in aggregate by 2040. The proceeds from the transaction are expected to supercharge growth and reduce the need for new segment investments as computing scales.
Management Comments
- Michael Klein, Chairman and CEO of Churchill Capital Corp X, stated, 'Infleqtion stands out with its breakthrough neutral atom platform and proven engineering capabilities, already delivering meaningful impact in quantum computing and sensing. We are excited to support Infleqtion's leadership team as they advance the quantum era and create enduring value for shareholders.'
- Matt Kinsella, CEO and founding investor of Infleqtion, commented, 'We have reached a critical inflection point in our journey from R&D to commercialization, and this partnership is a testament to our team's incredible work. As we move from successful pilots to full-scale production for our leading customers, this partnership with Churchill provides us with the additional capital and strategic expertise required to accelerate commercialization, expand our market leadership, and meet the rapidly growing demand for quantum solutions across AI, national security, and space.'
- Kenneth Safar, Managing Director at Maverick Silicon, noted, 'Quantum is a defining technology opportunity of the coming decade, and we see neutral atoms as the modality best positioned to succeed. Infleqtion is demonstrating how quantum can be applied to enhance AI today and deliver real performance gains across computing and sensing. That's why we backed Infleqtion early and continue to invest behind them, because we believe in the vision, the technology, and the team. Now they have a growing commercial portfolio and clear leadership in solutions and are poised to build a category-defining public company.'
Industry Context
The quantum technology industry is in its early stages but is considered critical for national competitiveness, with significant global investments (e.g., China investing over $15 billion, approximately double the U.S. investment). The quantum computing and sensing markets are projected to exceed $160 billion in aggregate by 2040. Infleqtion's neutral atom-based technology positions it as a frontrunner, offering inherent advantages in scalability, qubit quantity (1,600 physical qubits), and quality (99.73% entangling fidelity), surpassing other modalities in key metrics. The company's full-stack approach, integrating hardware and software, aims to address classical computing bottlenecks and unlock new applications in AI, defense, energy, and space.
Comparison to Industry Standards
- Infleqtion's neutral atom technology has achieved 1,600 physical qubits, a record qubit array, outpacing other modalities in physical qubit count.
- The company has demonstrated 99.73% entangling fidelity, which is the highest 2-qubit fidelity achieved by a neutral atom company.
- Infleqtion is one of only two companies to demonstrate a real-world application using logical qubits (on two logical qubits), positioning it as a front-runner on the path to quantum advantage.
- The company's LTM revenue of ~$29 million as of June 30, 2025, and ~$50 million in booked and awarded business for 2025E, along with a $300 million+ identified pipeline, indicates significant commercial traction compared to other emerging quantum companies.
- The $1.8 billion pre-money equity valuation is presented as an attractive entry point compared to observed market capitalizations of public peers like IonQ ($13.9B YTD high, $12.4B current), D-Wave ($0.6B), Rigetti ($0.4B), and QCI ($0.3B), which have lower LTM revenues.
Management Changes
| Role | Previous Person | New Person | Effective Date | Reason |
|---|---|---|---|---|
| Chief Executive Officer | NA | Matt Kinsella | April 2024 (appointed as CEO of Infleqtion) | To lead Infleqtion's next phase of commercialization and growth. |
| Chief Science Officer | NA | Dana Anderson | NA | Founding role, building upon Nobel Prize-winning research. |
| Chief Technology Officer | NA | Pranav Gokhale | NA | Co-founder, with nearly 20 years of quantum technology experience. |
| Chief Strategy Officer | NA | Paul Lipman | NA | NA |
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Company Name Change | Churchill Capital Corp X will change its name to Infleqtion, Inc. upon domestication. | Prior to Closing | Reflects the new identity of the combined public entity. |
| Jurisdiction Change (Domestication) | Churchill Capital Corp X will deregister as a Cayman Islands exempted company and domesticate as a Delaware corporation. | At least one day prior to Closing | Aligns the corporate structure with U.S. legal and regulatory frameworks for the combined entity. |
| Board of Directors Composition | The board of directors of the combined company will consist of seven (7) or nine (9) directors, with one (1) or two (2) directors designated by the Sponsor (Churchill Sponsor X LLC). | Immediately following the First Effective Time | Ensures representation from the SPAC sponsor while allowing Infleqtion to determine the majority of the board, subject to citizenship requirements to avoid foreign ownership/control. |
| Equity Incentive Plan Adoption | SPAC will approve and adopt an equity incentive plan with an initial share pool reserve of 13% of total outstanding common stock (fully diluted) and an annual evergreen increase of 5%. | Prior to Closing Date (subject to stockholder approval) | Provides a mechanism for attracting and retaining talent through equity compensation in the combined company. |
| Employee Stock Purchase Plan Adoption | SPAC will approve and adopt an employee stock purchase plan with an initial share pool reserve of 2% of total outstanding common stock (fully diluted) and an annual evergreen increase of 1%. | Prior to Closing Date (subject to stockholder approval) | Offers employees an opportunity to acquire company stock, fostering alignment and retention. |
| Lock-Up Provisions | All existing Infleqtion shareholders and Churchill X's sponsor shares will be subject to a 180-day lock-up period post-closing, with potential for early release if the VWAP equals or exceeds $12.00 per share over 15 trading days within 180 consecutive trading days. | Closing Date | Aims to stabilize the stock price post-merger by restricting immediate sales by major shareholders, demonstrating long-term commitment. |
Related Party Transactions
- Churchill Capital Corp X (SPAC) and M. Klein & Company, through its affiliate The Klein Group, LLC (Advisor), entered into an Advisory Agreement. The Advisor will provide financial advisory, strategic consulting, and business development services for a fixed cash retainer fee of $250,000 per quarter for an initial term of two years, renewable for an additional one-year term. The agreement also includes provisions for potential additional fees if the Client undertakes capital markets financing (no less than 5% of total underwriting syndicate fees) or strategic investments (not exceeding 3% of gross proceeds).
- The Amended and Restated Sponsor Agreement details voting commitments and transfer restrictions for Churchill Sponsor X LLC (Sponsor) and Insiders, including the vesting of 1,500,000 Sponsor shares based on a $12.00 VWAP triggering event within five years of closing, or forfeiture if not met. This agreement also outlines indemnification for Sponsor Indemnitees by SPAC, excluding claims against the Trust Account.
Stakeholder Impact
- **Shareholders (Existing Infleqtion)**: Will roll 100% of their existing equity into the combined company, aligning their long-term interests with the public entity. Their shares will be subject to a 180-day lock-up period.
- **Shareholders (Existing Churchill X)**: Will become shareholders of the combined Infleqtion, Inc. The transaction provides an attractive entry point at a $1.8 billion pre-money equity value. They will vote on the business combination and have redemption rights for their shares.
- **PIPE Investors**: Will acquire common stock at $10.00 per share, contributing over $125 million in incremental financing, demonstrating confidence in the combined entity's prospects.
- **Employees**: The combined company plans to adopt an equity incentive plan and an employee stock purchase plan, providing opportunities for equity ownership and aligning employee interests with company performance. Key personnel are expected to remain with the combined company.
- **Customers (NVIDIA, U.S. Department of Defense, NASA, U.K. government)**: Will benefit from accelerated technology and product roadmap, expanded applications, and scaled customer adoption, potentially leading to more advanced quantum solutions.
- **Suppliers/Partners**: Infleqtion's reliance on strategic partners and third-party suppliers for components and services means continued business opportunities, but also potential risks from supply chain disruptions.
- **Management**: The existing management team of Infleqtion will lead the combined company, with new board members providing strategic oversight and expertise.
Next Steps
- Churchill X will file a registration statement on Form S-4 with the SEC, including preliminary and definitive proxy statements, to solicit shareholder approval for the proposed transaction.
- The Registration Statement needs to be declared effective by the SEC.
- A special meeting of Churchill X shareholders will be convened to vote on the business combination and other related matters.
- Infleqtion will solicit written consent from its stockholders to approve the Merger Agreement and Transactions.
- The Domestication of Churchill X from a Cayman Islands exempted company to a Delaware corporation will occur at least one day prior to the Closing.
- The closing of the PIPE Investment will occur substantially concurrently with the consummation of the Transactions.
- The combined company, Infleqtion, Inc., is expected to be listed on a leading North American exchange under the ticker INFQ.
- Infleqtion will accelerate its technology and product roadmap and expand applications to new end markets using the transaction proceeds.
- SPAC will approve and adopt an equity incentive plan and an employee stock purchase plan, and file an effective registration statement on Form S-8 for shares issuable under these plans and the 2017 Plan.
Key Dates
| Date | Description |
|---|---|
| May 13, 2025 | Date of the original Registration Rights Agreement of Churchill and the original letter agreement from the Sponsor and Insiders to Churchill. |
| May 15, 2025 | Date of Churchill's final prospectus related to its initial public offering filed with the SEC. |
| May 23, 2025 | Date of the Non-Disclosure Agreement between SPAC and the Company. |
| June 4, 2025 | Colorado Senate Bill 25-126, the Uniform Antitrust Pre-Merger Notification Act, signed into law. |
| June 30, 2025 | Infleqtion's trailing twelve-month revenue was approximately $29 million; cash on hand was $88 million; trailing twelve-month cash burn was $21 million. Churchill X cash in trust was ~$416 million. |
| September 8, 2025 | Date of the Agreement and Plan of Merger and Reorganization, Amended and Restated Sponsor Agreement, Subscription Agreements, and Advisory Agreement. Also, the date of the press release and investor presentation announcing the Transactions. |
| December 27, 2024 | Date of the Fourth Amended and Restated Certificate of Incorporation of the Company and the Fourth Amended and Restated Voting Agreement. |
| March 1, 2026 | Termination Date for the Merger Agreement if transactions are not consummated. |
| March 21, 2026 | Termination date for the Subscription Agreements. |
| May 15, 2027 | Deadline for SPAC to consummate a Business Combination (or August 15, 2027 if LOI/definitive agreement is executed by May 15, 2027). |
Recommendation
buyThe merger with Churchill Capital Corp X provides Infleqtion with substantial capital (over $540 million gross proceeds, including a significant PIPE) to accelerate its technology roadmap and commercialization efforts in the rapidly growing quantum computing and sensing markets, projected to reach over $160 billion by 2040. Infleqtion demonstrates strong technical leadership with record-setting qubits and entangling fidelity, along with proven commercial traction (80% CAGR in LTM revenue, $300M+ pipeline). The $1.8 billion pre-money valuation appears attractive relative to public peers, and the 100% equity rollover by existing shareholders, coupled with a lock-up, signals strong alignment and long-term commitment. While risks associated with emerging technology exist, the strategic positioning, strong funding, and clear growth trajectory make this a compelling 'buy' for investors seeking exposure to the quantum sector.
Keywords
Quantum Technology, Neutral Atoms, Quantum Computing, Precision Sensing, SPAC Merger, Churchill Capital Corp X, ColdQuanta, Infleqtion, Artificial Intelligence, National Security, Space Technology, SEC Filing, PIPE Investment, Commercialization, Qubits, Financial Advisory
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.